Johnson and Johnson MedTech

Johnson & Johnson has received CE mark approvals for CEREGLIDE 42 and CEREGLIDE 57. Together with CEREGLIDE 71 and INNERGLIDE 7 delivery aid, these additions expand Johnson & Johnson MedTech Stroke Solutions Portfolio in EMEA

“We designed this multi-axial system to address procedural challenges physicians face when treating stroke,” said Christian Cuzick, Worldwide President, Neurovascular, MedTech, Johnson & Johnson. “With this expanded portfolio, we’re simplifying decisions, enhancing consistency across device sizes, and reinforcing our commitment to helping improve patient outcomes.” “With the addition of CEREGLIDE 42, CEREGLIDE 57 and INNERGLIDE...

Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)

World’s #1 Selling Contact Lens Brand ACUVUE Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort The First Toric Lens to have an Optimised Design according to Cylinder Power. 4 September 2025 -- Wokingham, UK -- Today, Johnson & Johnson, a global leader in eye health, announced the launch of a new product...

Johnson & Johnson MedTech Joins Experts to Define and Classify Surgical Site Outcomes

Healthcare experts call for consistent definitions in the assessment, reporting, and monitoring of surgical woundsA standardized classification system offers potential to capture and treat underreported surgical site infections and other wound complications 5 December 2024 – New Brunswick, NJ, US – Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today joined...